secwatch / observer
8-K filed August 3, 2021, 7:59 PM ET ticker ASMB CIK 0001426800
leadership confidence high sentiment neutral materiality 0.35

Assembly Biosciences promotes Okazaki to COO and Samar to CFO effective August 1

ASSEMBLY BIOSCIENCES, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Michael P. Samar

Chief Financial Officer
ASMB · ASSEMBLY BIOSCIENCES, INC.
Effective
2021-08-01
Filed
August 3, 2021, 7:59 PM ET
Michael P. Samar, 49, has been promoted to the position of Chief Financial Officer.
Role change

Jason A. Okazaki

Chief Operating Officer
ASMB · ASSEMBLY BIOSCIENCES, INC.
Effective
2021-08-01
Filed
August 3, 2021, 7:59 PM ET
Jason A. Okazaki, 45, has been promoted to the position of Chief Operating Officer

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael P. Samar changed role as Chief Financial Officer at ASSEMBLY BIOSCIENCES, INC..

Action
promoted
Role
Chief Financial Officer
Exact text from the filing
Michael P. Samar, 49, has been promoted to the position of Chief Financial Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jason A. Okazaki changed role as Chief Operating Officer at ASSEMBLY BIOSCIENCES, INC..

Action
promoted
Role
Chief Operating Officer
Exact text from the filing
Jason A. Okazaki, 45, has been promoted to the position of Chief Operating Officer
View on SEC.gov

ASSEMBLY BIOSCIENCES, INC. filing history →

Source: SEC EDGAR
accession 0001564590-21-040208
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.